A 65-year-old female client with a long history of acute coronary syndrome (ACS) had two cardiac stents placed via percutaneous coronary intervention. After this procedure, she was started on aspirin 325 mg orally once daily and clopidogrel 75 mg orally once daily. The nurse is preparing to provide education about each of these drugs. For each health teaching statement below. indicate whether it is Essential (necessary or appropriate drug information) or Unrelated (not relevant or appropriate drug information) for the client.

A. "Report any unexpected bleeding to your primary health care provider.": Aspirin and clopidogrel inhibit platelet function, increasing the risk of bleeding. Promptly reporting unusual bruising, nosebleeds, or gastrointestinal bleeding is crucial for patient safety. B. "Continue taking your newly prescribed medications until your prescriber tells you not to do so.": Consistent use of antiplatelet therapy is essential to prevent stent thrombosis and recurrent ACS. Abrupt discontinuation could result in life-threatening clot formation. C. "Drink a full glass of water with each dose of your new medications.": While generally good advice for some medications, it is not specifically required for aspirin or clopidogrel and does not impact their effectiveness or safety. D. "Eat foods high in vitamin K and calcium to help prevent clotting.": Vitamin K promotes clotting, which could counteract the antiplatelet effects of aspirin and clopidogrel. This advice is not appropriate or beneficial for the patient. E. "Avoid taking other medications that can cause bleeding, such as NSAIDs like ibuprofen.": NSAIDs increase bleeding risk when combined with antiplatelet therapy. Avoiding these medications is essential to reduce the likelihood of serious hemorrhagic complications.